Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB04884"
Predicate | Value (sorted: none) |
---|---|
drugbank:description |
"Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation in December 2004. In October 2005, the company received a FDA Non-Approvable letter from the FDA, at which time they planned to work with regulators to address outstanding questions."
|
rdfs:label |
"Dapoxetine"
|
drugbank:drugCategory | |
rdf:type |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt
The resource does not appear as an object